Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|May 5, 2016
Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspectiveSaeed Ahmadiani, Shekoufeh Nikfar
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 23, 2006
Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trialsRoja Rahimi, Shekoufeh Nikfar, Mohammad Abdollahi
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 28, 2012
The efficacy and tolerability of exenatide in comparison to placebo; a systematic review and meta-analysis of randomized clinical trialsShekoufeh Nikfar, Mohammad Abdollahi, Pooneh Salari
Expert Opinion on Drug Metabolism & Toxicology|September 17, 2020
Antibiotic resistance propagation through probioticsMarzieh Daniali, Shekoufeh Nikfar, Mohammad Abdollahi
Clinical Therapeutics|June 17, 2008
Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trialsRoja Rahimi, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Review of Pharmacoeconomics & Outcomes Research|August 1, 2022
A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trialsMarzieh Nosrati, Shekoufeh Nikfar, Mandana Hasanzad
Expert Opinion on Drug Metabolism & Toxicology|April 26, 2024
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new?Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Opinion on Investigational Drugs|February 17, 2024
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugsShilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Opinion on Pharmacotherapy|September 27, 2019
An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipationMarzieh Daniali, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Review of Clinical Pharmacology|May 17, 2021
Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD)Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
Pageof 20